vs
Side-by-side financial comparison of Clarus Corp (CLAR) and ImmunityBio, Inc. (IBRX). Click either name above to swap in a different company.
Clarus Corp is the larger business by last-quarter revenue ($65.4M vs $38.3M, roughly 1.7× ImmunityBio, Inc.). Clarus Corp runs the higher net margin — -47.8% vs -161.8%, a 114.0% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs -8.4%). Clarus Corp produced more free cash flow last quarter ($11.6M vs $-71.3M).
Clarus Corp is a global designer, manufacturer, and distributor of high-performance outdoor recreation, climbing, camping, and lifestyle products. It manages a portfolio of leading consumer brands, serving outdoor enthusiasts, professional athletes, and retail partners across North America, Europe, and the Asia-Pacific region, with a focus on innovative, durable gear for active lifestyles.
ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.
CLAR vs IBRX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $65.4M | $38.3M |
| Net Profit | $-31.3M | $-61.9M |
| Gross Margin | 27.7% | 99.0% |
| Operating Margin | -59.6% | -169.0% |
| Net Margin | -47.8% | -161.8% |
| Revenue YoY | -8.4% | 407.0% |
| Net Profit YoY | 52.3% | -4.7% |
| EPS (diluted) | $-0.81 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $65.4M | $38.3M | ||
| Q3 25 | $69.3M | $32.1M | ||
| Q2 25 | $55.2M | $26.4M | ||
| Q1 25 | $60.4M | $16.5M | ||
| Q4 24 | $71.4M | $7.6M | ||
| Q3 24 | $67.1M | $6.1M | ||
| Q2 24 | $56.5M | — | ||
| Q1 24 | $69.3M | — |
| Q4 25 | $-31.3M | $-61.9M | ||
| Q3 25 | $-1.6M | $-67.3M | ||
| Q2 25 | $-8.4M | $-92.6M | ||
| Q1 25 | $-5.2M | $-129.6M | ||
| Q4 24 | $-65.5M | $-59.2M | ||
| Q3 24 | $-3.2M | $-85.7M | ||
| Q2 24 | $-5.5M | — | ||
| Q1 24 | $21.9M | — |
| Q4 25 | 27.7% | 99.0% | ||
| Q3 25 | 35.1% | 99.4% | ||
| Q2 25 | 35.6% | 99.5% | ||
| Q1 25 | 34.4% | 99.6% | ||
| Q4 24 | 33.4% | — | ||
| Q3 24 | 35.0% | — | ||
| Q2 24 | 36.1% | — | ||
| Q1 24 | 35.9% | — |
| Q4 25 | -59.6% | -169.0% | ||
| Q3 25 | -4.4% | -173.5% | ||
| Q2 25 | -19.7% | -269.8% | ||
| Q1 25 | -11.2% | -390.1% | ||
| Q4 24 | -70.2% | -919.0% | ||
| Q3 24 | -8.0% | -1314.3% | ||
| Q2 24 | -14.4% | — | ||
| Q1 24 | -9.8% | — |
| Q4 25 | -47.8% | -161.8% | ||
| Q3 25 | -2.3% | -209.8% | ||
| Q2 25 | -15.3% | -350.3% | ||
| Q1 25 | -8.7% | -784.9% | ||
| Q4 24 | -91.8% | -783.4% | ||
| Q3 24 | -4.7% | -1404.0% | ||
| Q2 24 | -9.7% | — | ||
| Q1 24 | 31.6% | — |
| Q4 25 | $-0.81 | $-0.06 | ||
| Q3 25 | $-0.04 | $-0.07 | ||
| Q2 25 | $-0.22 | $-0.10 | ||
| Q1 25 | $-0.14 | $-0.15 | ||
| Q4 24 | $-1.72 | $-0.08 | ||
| Q3 24 | $-0.08 | $-0.14 | ||
| Q2 24 | $-0.14 | — | ||
| Q1 24 | $0.57 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.7M | $242.8M |
| Total DebtLower is stronger | $0 | — |
| Stockholders' EquityBook value | $196.4M | $-500.5M |
| Total Assets | $249.0M | $501.9M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.7M | $242.8M | ||
| Q3 25 | $29.5M | $257.8M | ||
| Q2 25 | $28.5M | $153.7M | ||
| Q1 25 | $41.3M | $61.6M | ||
| Q4 24 | $45.4M | $149.8M | ||
| Q3 24 | $36.4M | $130.4M | ||
| Q2 24 | $46.2M | — | ||
| Q1 24 | $47.5M | — |
| Q4 25 | $0 | — | ||
| Q3 25 | $2.0M | — | ||
| Q2 25 | $1.9M | — | ||
| Q1 25 | $1.9M | — | ||
| Q4 24 | $1.9M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $37.0K | — |
| Q4 25 | $196.4M | $-500.5M | ||
| Q3 25 | $225.8M | $-524.3M | ||
| Q2 25 | $225.1M | $-570.7M | ||
| Q1 25 | $229.3M | $-591.4M | ||
| Q4 24 | $233.1M | $-489.1M | ||
| Q3 24 | $308.5M | $-745.1M | ||
| Q2 24 | $307.3M | — | ||
| Q1 24 | $310.4M | — |
| Q4 25 | $249.0M | $501.9M | ||
| Q3 25 | $283.1M | $519.0M | ||
| Q2 25 | $286.5M | $402.1M | ||
| Q1 25 | $292.8M | $303.8M | ||
| Q4 24 | $294.1M | $382.9M | ||
| Q3 24 | $375.3M | $364.6M | ||
| Q2 24 | $369.4M | — | ||
| Q1 24 | $377.0M | — |
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.01× | — | ||
| Q2 25 | 0.01× | — | ||
| Q1 25 | 0.01× | — | ||
| Q4 24 | 0.01× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $12.5M | $-70.4M |
| Free Cash FlowOCF − Capex | $11.6M | $-71.3M |
| FCF MarginFCF / Revenue | 17.7% | -186.2% |
| Capex IntensityCapex / Revenue | 1.4% | 2.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-9.9M | $-308.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.5M | $-70.4M | ||
| Q3 25 | $-5.7M | $-68.9M | ||
| Q2 25 | $-9.4M | $-79.7M | ||
| Q1 25 | $-2.1M | $-85.9M | ||
| Q4 24 | $16.6M | $-85.1M | ||
| Q3 24 | $-8.3M | $-98.8M | ||
| Q2 24 | $834.0K | — | ||
| Q1 24 | $-16.4M | — |
| Q4 25 | $11.6M | $-71.3M | ||
| Q3 25 | $-7.0M | $-69.6M | ||
| Q2 25 | $-11.3M | $-80.8M | ||
| Q1 25 | $-3.3M | $-87.0M | ||
| Q4 24 | $14.4M | $-87.3M | ||
| Q3 24 | $-9.4M | $-101.6M | ||
| Q2 24 | $-744.0K | — | ||
| Q1 24 | $-18.3M | — |
| Q4 25 | 17.7% | -186.2% | ||
| Q3 25 | -10.0% | -217.2% | ||
| Q2 25 | -20.4% | -305.9% | ||
| Q1 25 | -5.4% | -526.9% | ||
| Q4 24 | 20.1% | -1155.4% | ||
| Q3 24 | -14.0% | -1663.2% | ||
| Q2 24 | -1.3% | — | ||
| Q1 24 | -26.3% | — |
| Q4 25 | 1.4% | 2.4% | ||
| Q3 25 | 1.8% | 2.3% | ||
| Q2 25 | 3.4% | 4.1% | ||
| Q1 25 | 2.0% | 6.8% | ||
| Q4 24 | 3.1% | 28.0% | ||
| Q3 24 | 1.6% | 45.7% | ||
| Q2 24 | 2.8% | — | ||
| Q1 24 | 2.7% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.75× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLAR
| Other | $37.1M | 57% |
| Outdoor Segment | $25.3M | 39% |
| Adventure Segment | $3.0M | 5% |
IBRX
Segment breakdown not available.
